Patents Assigned to Bioggnerix AG
  • Erythropoietin solution formulation
    Patent number: 7468351
    Abstract: A stable pharmaceutical formulation of erythropoietin is disclosed which contains tris-(hydrox-ymethyl)-aminomethane as stabilizer, whereby the formulation does not contain amino acids or human serumalbumin.
    Type: Grant
    Filed: December 1, 2004
    Date of Patent: December 23, 2008
    Assignee: Bioggnerix AG
    Inventors: Stefan Arnold, Okke Franssen, Albert Mekking